CardioInsight 2 - Non-responder (CardioInsight2)
Primary Purpose
Heart Failure
Status
Recruiting
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Electrical Activation Mapping Guided Cardiac resynchronization therapy
Sponsored by
About this trial
This is an interventional treatment trial for Heart Failure
Eligibility Criteria
Inclusion Criteria:
- Adult (aged 18 or above) of both sexes
- Ischemic or non-ischemic cause of heart failure
- QRS duration > 120 ms, non -LBBB type of conduction disturbance
- NYHA class III or above
- Informed consent by the patient
- Already received stable dose of guideline directed medical therapy for at least 3 months
Exclusion Criteria:
- LBBB patients
- Pregnant women
- Participation in another study
- Patient with contraindication to left ventricle catheterization by a retrograde aortic approach
Sites / Locations
- The Chinese University of Hong KongRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Treatment
Arm Description
Outcomes
Primary Outcome Measures
Left Ventricle end systolic volume reduction
The responder rate of greater than 10% of LV end systolic volume reduction measured by echocardiogram.
Secondary Outcome Measures
Electrical desynchrony index
The acute electrical desynchrony indices (the standard deviation of activation times throughout the epicardium) of different methods of CRT delivery. Lower indicate larger improvement.
Hemodynamic response monitoring
Monitor the difference in hemodynamic responses of different methods of CRT delivery. The hemodynamic response will be maximal dp/dt as measured by pressure wire introduced into the left ventricle during the procedure.
Procedure duration of different methods of CRT delivery
Procedure duration of the optimal CRT delivery method as determined by the best improvement in electrical desynchrony indices.
Implantation success rate of different methods of CRT delivery
Implantation success rate of the optimal CRT delivery method as determined by the best improvement in electrical desynchrony indices.
Cine images and chest X ray
Cine images (PA, LAO 300, RAO 300) and Chest X ray (PA view) of patients will be obtained for evaluation of changes in disease
Echocardiogram parameters: left ventricular systolic and diastolic volume
Echocardiogram parameters: left ventricular systolic and diastolic volume at baseline, 3 months and 6 months.
Echocardiogram parameters: left ventricular ejection fraction
Echocardiogram parameters: left ventricular ejection fraction at baseline, 3 months and 6 months
Echocardiogram parameters: degree of mitral regurgitation
Echocardiogram parameter: degree of mitral regurgitation at baseline, 3 months and 6 months.
Echocardiogram parameters: strain imaging
Echocardiogram parameters: strain imaging at baseline, 3 months and 6 months
Change in New York Heart Association (NYHA) class
Overall changes in QoL measured by change in NYHA class at baseline, 3 months and 6 months.
Device set-up parameter: defibrillation threshold
Device parameters including defibrillation threshold at implant and 6 months follow-up.
Post-operation Complication rate
Peri-operative and 6 months follow-up complications rate:
Thromboembolic event
Dislodgement and migration of pacing leads
Phrenic nerve stimulation
Others
Change in 6 minute hall walk test
Compare result of 6 minute hall walk test at baseline, 3 months and 6 months.
Change in HF Patient Global Assessment Questionnaire
Compare result of HF Patient Global Assessment Questionnaire at baseline, 3 months and 6 months.
Change in quality of life
Change in quality of life assessed by Minnesota's living with heart failure (MLWHF) questionnaire at baseline, 3 months and 6 months.
Device set-up parameter: defibrillation sensitivity
Device parameters including defibrillation sensitivity at implant and 6 months follow-up.
Device set-up parameter: lead impedance
Device parameters including lead impedance of pacing leads at implant and 6 months follow-up.
Full Information
NCT ID
NCT05555992
First Posted
September 15, 2022
Last Updated
September 22, 2022
Sponsor
Chinese University of Hong Kong
1. Study Identification
Unique Protocol Identification Number
NCT05555992
Brief Title
CardioInsight 2 - Non-responder
Acronym
CardioInsight2
Official Title
Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy for Non-responder
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 2, 2020 (Actual)
Primary Completion Date
August 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese University of Hong Kong
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Background Cardiac Resynchronization Therapy (CRT) is proven to improve survival and heart function of patient with certain electrical conduction abnormality and heart failure. However, in patient with certain electrical conduction abnormality, being nonresponder is observed in up to 40% in patient receiving CRT. Conventionally the surgical approach of CRT is to implant one pacing lead in the right heart and one in the left heart to resynchronize the contraction and the pacing lead in the left heart is usually placed in the posterior or lateral portion of the left heart. However, this single approach may not be optimal, especially for those patients with conduction abnormality known to have no response to CRT. Purpose of the clinical investigation. The purpose of the Electrical Activation Guided CRT for Nonresponders Study is to study the effectiveness of an addition of Hisbundle pacing approach to CRT nonresponder by direct His-bundle pacing to improve the responder rate of nonresponder of conventional CRT and a tailored made approach to CRT procedure by using a noninvasive globally mapping system studying the electrical conduction under different approaches to delivery CRT. The pacing approach that optimally corrects conduction abnormality will be determined before the actual addition of new lead procedure.
Conduct of the Investigation This study will include 18 patients already implanted with device delivering conventional CRT that known to have no response to the conventional CRT after 6 months of the CRT therapy from Prince of Wales Hospital, Hong Kong. You will be followed in the device clinic as per usual care after your participation in the study is completed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
18 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Treatment
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Electrical Activation Mapping Guided Cardiac resynchronization therapy
Intervention Description
To study the feasibility to optimize configuration of CRT delivery for acute correction of electrical dyssynchrony using a noninvasive mapping of global electrical activation
Primary Outcome Measure Information:
Title
Left Ventricle end systolic volume reduction
Description
The responder rate of greater than 10% of LV end systolic volume reduction measured by echocardiogram.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Electrical desynchrony index
Description
The acute electrical desynchrony indices (the standard deviation of activation times throughout the epicardium) of different methods of CRT delivery. Lower indicate larger improvement.
Time Frame
During procedure
Title
Hemodynamic response monitoring
Description
Monitor the difference in hemodynamic responses of different methods of CRT delivery. The hemodynamic response will be maximal dp/dt as measured by pressure wire introduced into the left ventricle during the procedure.
Time Frame
During procedure
Title
Procedure duration of different methods of CRT delivery
Description
Procedure duration of the optimal CRT delivery method as determined by the best improvement in electrical desynchrony indices.
Time Frame
During procedure
Title
Implantation success rate of different methods of CRT delivery
Description
Implantation success rate of the optimal CRT delivery method as determined by the best improvement in electrical desynchrony indices.
Time Frame
During procedure
Title
Cine images and chest X ray
Description
Cine images (PA, LAO 300, RAO 300) and Chest X ray (PA view) of patients will be obtained for evaluation of changes in disease
Time Frame
6 months
Title
Echocardiogram parameters: left ventricular systolic and diastolic volume
Description
Echocardiogram parameters: left ventricular systolic and diastolic volume at baseline, 3 months and 6 months.
Time Frame
6 months
Title
Echocardiogram parameters: left ventricular ejection fraction
Description
Echocardiogram parameters: left ventricular ejection fraction at baseline, 3 months and 6 months
Time Frame
6 months
Title
Echocardiogram parameters: degree of mitral regurgitation
Description
Echocardiogram parameter: degree of mitral regurgitation at baseline, 3 months and 6 months.
Time Frame
6 months
Title
Echocardiogram parameters: strain imaging
Description
Echocardiogram parameters: strain imaging at baseline, 3 months and 6 months
Time Frame
6 months
Title
Change in New York Heart Association (NYHA) class
Description
Overall changes in QoL measured by change in NYHA class at baseline, 3 months and 6 months.
Time Frame
6 months
Title
Device set-up parameter: defibrillation threshold
Description
Device parameters including defibrillation threshold at implant and 6 months follow-up.
Time Frame
6 months
Title
Post-operation Complication rate
Description
Peri-operative and 6 months follow-up complications rate:
Thromboembolic event
Dislodgement and migration of pacing leads
Phrenic nerve stimulation
Others
Time Frame
6 months
Title
Change in 6 minute hall walk test
Description
Compare result of 6 minute hall walk test at baseline, 3 months and 6 months.
Time Frame
6 months
Title
Change in HF Patient Global Assessment Questionnaire
Description
Compare result of HF Patient Global Assessment Questionnaire at baseline, 3 months and 6 months.
Time Frame
6 months
Title
Change in quality of life
Description
Change in quality of life assessed by Minnesota's living with heart failure (MLWHF) questionnaire at baseline, 3 months and 6 months.
Time Frame
6 months
Title
Device set-up parameter: defibrillation sensitivity
Description
Device parameters including defibrillation sensitivity at implant and 6 months follow-up.
Time Frame
6 months
Title
Device set-up parameter: lead impedance
Description
Device parameters including lead impedance of pacing leads at implant and 6 months follow-up.
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult (aged 18 or above) of both sexes
Ischemic or non-ischemic cause of heart failure
QRS duration > 120 ms, non -LBBB type of conduction disturbance
NYHA class III or above
Informed consent by the patient
Already received stable dose of guideline directed medical therapy for at least 3 months
Exclusion Criteria:
LBBB patients
Pregnant women
Participation in another study
Patient with contraindication to left ventricle catheterization by a retrograde aortic approach
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel Xu
Phone
35051518
Ext
1518
Email
danielxu@cuhk.edu.hk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Byran Yan
Organizational Affiliation
Chinese University of Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Chinese University of Hong Kong
City
Shatin
ZIP/Postal Code
999077
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniel Xu
Phone
35051518
Ext
1518
Email
danielxu@cuhk.edu.hk
12. IPD Sharing Statement
Learn more about this trial
CardioInsight 2 - Non-responder
We'll reach out to this number within 24 hrs